Novartis Standing In Patent Suit V. Teva Still Unclear

Law360, New York (October 21, 2009, 8:12 PM EDT) -- Efforts by drugmaker Teva Pharmaceuticals USA Inc. to dismiss rival Novartis Pharmaceuticals Corp.'s patent infringement suit over generic herpes medications have been stymied in federal court following a judge's ruling that he did not have sufficient information to decide whether the plaintiffs had proper standing to bring the case.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey on Wednesday determined that an issue of fact remained as to whether Novartis subsidiaries owned exclusive licenses or otherwise were titleholders to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.